Leveraging HCV Phylogenetic Networks to Prevent HIV and Other Blood Borne Infections Among People Who Inject Drugs

Medicine & Life Sciences

1. HIV 100%
2. Pharmaceutical Preparations 60%
3. Infections 58%
4. Public Health 32%
5. Hepatitis 28%
6. HIV Infections 27%
7. Epidemics 26%
8. Eastern Africa 20%
9. Geography 19%
10. Kenya 17%
11. Drug Monitoring 17%
12. Syringes 17%
13. Administrative Personnel 15%
14. Genetic Variation 14%
15. Needles 13%
16. Income 12%
17. Research Personnel 10%
18. Demography 9%
19. Morbidity 9%
20. Mortality 7%
21. Incidence 7%
22. Population 5%
23. Therapeutics 5%